Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
2008 Standout
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Gender differences in autoimmune demyelination in the mouse: Implications for multiple sclerosis
1996
Glutamate receptor ion channels
2005 Standout
Inflammation and Alzheimer's disease
2000 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Classification and natural history of clinically identifiable subtypes of cerebral infarction
1991 Standout
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Intracerebral haemorrhage
2009 Standout
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
1998 Standout
B cells and antibodies in CNS demyelinating disease
2001
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
1998 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Updating P300: An integrative theory of P3a and P3b
2007 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
1988 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Apoptosis of αβ T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: Its possible implications for recovery and acquired tolerance
1992
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
2005 Standout
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
1998 Standout
Pentoxifylline
1987 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE
1989
Diclofenac residues as the cause of vulture population decline in Pakistan
2004 StandoutNature
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation
2005
A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis
1988 Nature
Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)
2007
Stroke
2008 Standout
Hypertension and the risk of dementia in the elderly
1991
Demyelination: The Role of Reactive Oxygen and Nitrogen Species
1999
Parietal control of hand action
1994
Current management of ischaemic stroke.
1993
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
GABAergic Mechanisms in Epilepsy
2001
B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide
1999
Cardiac Myxomas
1995 Standout
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
2002 StandoutNature
Action recognition in the premotor cortex
1996 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
The Pathobiology of Vascular Dementia
2013 Standout
COX-2 inhibitors
1999 Standout
Cryptococcal Disease of the CNS in Immunocompetent Hosts: Influence of Cryptococcal Variety on Clinical Manifestations and Outcome
1995
Management of Cryptococcosis
1993
Secondary Stroke Prevention with Antiplatelet Drugs: Have We Reached the Ceiling?
2005
Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
1989
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Cutting Edge: Antisense Knockdown of Inducible Nitric Oxide Synthase Inhibits Induction of Experimental Autoimmune Encephalomyelitis in SJL/J Mice
1998 StandoutNobel
VENOUS THROMBOSIS FOLLOWING STROKES
1972
Management of Parkinson's disease: An evidence-based review
2002
Immune Invasion of the Central Nervous System Parenchyma and Experimental Allergic Encephalomyelitis, But Not Leukocyte Extravasation from Blood, Are Prevented in Macrophage-Depleted Mice
1998
Medical treatment of transient ischemic attacks: does it influence mortality?
1988
IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis
2006 Standout
Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks
1995
Acute Hypertensive Response in Patients With Stroke
2008
Gluten, major histocompatibility complex, and the small intestine
1992 Standout
"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.
1983
Left ventricular myxoma
1977
Cognition in Parkinson disease: An event‐related potential perspective
1982
Prostaglandin Endoperoxides. A New Concept Concerning the Mode of Action and Release of Prostaglandins
1974 StandoutNobel
Graft-vs.-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system.
1987
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty
1987
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
2016 StandoutNobel
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation
2004
Frontotemporal lobar degeneration
1998 Standout
Blood pressure, stroke, and coronary heart disease
1990 Standout
Effect of Prostaglandin E2 and Aspirin on the Secondary Aggregation of Human Platelets
1972
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
2007
Pharmacologic Control of Thromboembolic Complications of Cardiac-Valve Replacement
1971
Occurrence of drugs in German sewage treatment plants and rivers
1998 Standout
The nerve lesion in the carpal tunnel syndrome.
1976
Parietal Lobe: From Action Organization to Intention Understanding
2005 StandoutScience
Experimental Autoimmune Encephalomyelitis Induction in Genetically B Cell–deficient Mice
1996
Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet Aggregation
1974 StandoutNobel
Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids.
1989
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
2005 Standout
Works of G Danta being referenced
Controlled Trial of Dipyridamole in Cerebral Vascular Disease
1969
Inhibition of allergic encephalomyelitis by the iron chelating agent desferrioxamine: differential effect depending on type of sensitizing encephalitogen
1988 StandoutNobel
A double-blind, placebo-controlled crossover study of vigabatrin 2 g/day and 3 g/day in uncontrolled partial seizures
1996
Double‐Blind, Placebo‐Controlled, Lamotrigine in Treatment‐Resistant Generalised Epilepsy
1998
Reactivation of allergic encephalomyelitis by means of allogeneic confrontation
1985
Cerebral infarction due to presumed haemodynamic factors in ambulant hypertensive patients.
1987
Recovery of nerve conduction after a pneumatic tourniquet: observations on the hind-limb of the baboon
1972
Multiple emboli from left ventricular myxoma.
1969
Interactions of L-dopa and amantadine in patients with Parkinsonism
1973
Immunoregulation of passively induced allergic encephalomyelitis.
1986
Second Phase Platelet Aggregation Induced by Adenosine Diphosphate in Patients with Cerebral Vascular Disease and in Control Subjects
1970
Platelet adhesiveness in patients with cerebral vascular disease
1972
Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis
1986
Judgment of the visual vertical and horizontal in patients with parkinsonism
1975
Ophthalmological complications of cryptococcal meningitis.
1985
Hemisphere Function and Binocular Depth Perception
1978
Platelet adhesiveness in cerebrovascular disease
1970